Evolution and Prognostic Significance of Heart Involvement in Patients With Systemic AL-amyloidosis

Clinical pharmacology and therapy
doi 10.32756/0869-5490-2019-2-49-56
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pharmapress LLC

Related search

Cardiac Involvement Is Underdiagnosed in Patients With Biopsy-Proven Systemic AL Amyloidosis

International Cardiovascular Forum Journal
2016English

Prognostic Significance of Heart Rate Turbulence Parameters in Patients With Chronic Heart Failure

BMC Cardiovascular Disorders
Cardiovascular MedicineCardiology
2014English

Prognostic Significance of Cerebral Metabolic Abnormalities in Patients With Congestive Heart Failure

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Renal Outcomes in Patients With AL Amyloidosis: Prognostic Factors, Renal Response and the Impact of Therapy

American Journal of Hematology
Hematology
2017English

015 Prognostic Significance of Plasma Concentrations of Procalcitonin in Patients With Suspected Heart Failure

Heart
Cardiovascular MedicineCardiology
2013English

Efficacy of Bortezomib in Systemic AL Amyloidosis With Relapsed/Refractory Clonal Disease

Haematologica
Hematology
2008English

Prognostic Significance of Hyponatremia in ST-elevation Myocardial Infarction/Heart Failure Patients

Cureus
2019English

Quantitative Assessment of Systolic and Diastolic Function in Patients With Systemic Amyloidosis

Journal of Cardiovascular Magnetic Resonance
Nuclear MedicineRadiologyUltrasound TechnologyCardiologyFamily PracticeRadiologicalCardiovascular MedicineImaging
2016English

Systemic Light Chain Amyloidosis With Cardiac and Renal Involvements in a Patient With Heart Failure

Cardiology and Cardiovascular Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy